SlideShare ist ein Scribd-Unternehmen logo
1 von 10
URS-USER REQUIREMENT SPECIFICATIONS
Presented by
Girija G S
M PHARM 1ST SEM
DEPARTMENT OF
PHARMACEUTICS
MALLIGE COLLEGE OF
PHARMACY
1
2
USER REQUIREMENT SPECIFICATIONS-URS
→ Requirements regarding equipment is given by users called as
URS.
It includes,
 Size of equipment
 Speed of equipment
 Effectiveness of equipment
 Availability of spares, change parts
 Low dust and sound facilities
 Auto control systems
 Lesser breakdowns
 Overall good construction
3
 The requirement and specifications for the utility of equipment
should be defined by the user and documented in the URS.
 The URS should be used when selection of the required utility
or equipment from an approved supplier and to verify suitability
throughout the subsequent stages of qualification.
 They must be comprehensive. Each and every requirement relating to product safety,
identity, strength, purity, and quality must be identified.
 The URS can contain a large number of requirements and should therefore be
structured in a way that will permit easy access to information.
 The requirement specification must be formally reviewed and approved by the
pharmaceutical manufacturer.
4
The following guidelines should be followed during the production of
the URS:
 Each requirement statement to be uniquely referenced, and no
longer than 250words.
 Requirement statements should not be duplicated nor
contradicted.
 The URS should express requirements and not design solutions.
 Each requirement should be testable.
5
 The URS must be understood by both user and supplier; ambiguity
avoided.
 The use of diagrams is often useful
 Wherever possible, the URS should distinguish between
mandatory/regulatory requirements and desirable features.
6
U.R.S. for facilities is a statement spelling out, what the user wants in terms
of the facilities, he wants to create for the manufacturing of the
pharmaceutical formulations. It can expressed in the following manner.
The facility will be used for the manufacture of the following formulation and
volumes, namely:
1) Tablets-Coated 10L/Shift
2) Tablets-Uncoated 20L/Shift
3) Hard gelatin capsules 5L/Shift
4) Small volume parenterals 50K Amp/Shift
5) Large volume parenterals 20Kbottles of 500 ml/Shift
7
URS provides the following key benefits for the validation program:
1. Clarifies technical, quality, and documentation requirements to the
vendor(s).
2. Enables the pharmaceutical manufacturer to assess the technical,
regulatory, and commercial compliance (or otherwise) of submitted
bids against a formal specification.
3. Ensures the basis of a structured approach to the presentation of
information.
4. Provides a basis for testing and test acceptance criteria.
5. Provide a baseline for validation and verification..
8
Model Question
1) Write a note on
USR?
9
References
Pharmaceutical Process Validation, Second Edition, Revised and
Expanded, edited by Ira R. Berry, Robert a. Nash.
Validation in pharmaceutical industry; Equipment validation; A brief
review, Diksha Jindal, et al; Adesh University Journal of Medical
Sciences & Research. www.aujmsr.com
10

Weitere ähnliche Inhalte

Ähnlich wie Modern pharmaceutics

Concept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQConcept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQdhavalrock24
 
Developing Product Requirements For Medical Devices
Developing Product Requirements For Medical DevicesDeveloping Product Requirements For Medical Devices
Developing Product Requirements For Medical DevicesWalt Maclay
 
Regulatory affairs cmc , post approval regulatory affairs
Regulatory affairs   cmc , post approval regulatory affairsRegulatory affairs   cmc , post approval regulatory affairs
Regulatory affairs cmc , post approval regulatory affairsArjunDhawale
 
Medical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdfMedical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdfAlexander Sprauve
 
CONCEPT OF URS, DQ, IQ, OQ, PQ
CONCEPT OF URS, DQ, IQ, OQ, PQCONCEPT OF URS, DQ, IQ, OQ, PQ
CONCEPT OF URS, DQ, IQ, OQ, PQROHIT
 
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...Greenlight Guru
 
Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...EMMAIntl
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510kSigma
 
b.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptxb.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptxAarthi358332
 
Webinar on Device Registries as PMCF tools
Webinar on Device Registries as PMCF toolsWebinar on Device Registries as PMCF tools
Webinar on Device Registries as PMCF toolsaustinjoseph66
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...ulmedical
 
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptxGENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptxKishor Singha
 
Presentation: Conformity Assessment Evidence
Presentation: Conformity Assessment EvidencePresentation: Conformity Assessment Evidence
Presentation: Conformity Assessment EvidenceTGA Australia
 
CVH252009 Series
CVH252009 SeriesCVH252009 Series
CVH252009 SeriesTony Kenny
 
Abbott overview medical device human factors standards
Abbott overview medical device human factors standardsAbbott overview medical device human factors standards
Abbott overview medical device human factors standardsJones Wu
 
Quality Function Deployment (QFD) for Design Controls
Quality Function Deployment (QFD) for Design ControlsQuality Function Deployment (QFD) for Design Controls
Quality Function Deployment (QFD) for Design ControlsEMMAIntl
 
Pilot plant scale up techniques
Pilot plant scale up techniquesPilot plant scale up techniques
Pilot plant scale up techniquesSujit Patel
 

Ähnlich wie Modern pharmaceutics (20)

Concept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQConcept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQ
 
Developing Product Requirements For Medical Devices
Developing Product Requirements For Medical DevicesDeveloping Product Requirements For Medical Devices
Developing Product Requirements For Medical Devices
 
Regulatory affairs cmc , post approval regulatory affairs
Regulatory affairs   cmc , post approval regulatory affairsRegulatory affairs   cmc , post approval regulatory affairs
Regulatory affairs cmc , post approval regulatory affairs
 
Vaidation ppt.pptx
Vaidation ppt.pptxVaidation ppt.pptx
Vaidation ppt.pptx
 
Medical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdfMedical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdf
 
CONCEPT OF URS, DQ, IQ, OQ, PQ
CONCEPT OF URS, DQ, IQ, OQ, PQCONCEPT OF URS, DQ, IQ, OQ, PQ
CONCEPT OF URS, DQ, IQ, OQ, PQ
 
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
 
Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
 
b.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptxb.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptx
 
Supac
SupacSupac
Supac
 
Webinar on Device Registries as PMCF tools
Webinar on Device Registries as PMCF toolsWebinar on Device Registries as PMCF tools
Webinar on Device Registries as PMCF tools
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
 
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptxGENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
 
Presentation: Conformity Assessment Evidence
Presentation: Conformity Assessment EvidencePresentation: Conformity Assessment Evidence
Presentation: Conformity Assessment Evidence
 
CVH252009 Series
CVH252009 SeriesCVH252009 Series
CVH252009 Series
 
Abbott overview medical device human factors standards
Abbott overview medical device human factors standardsAbbott overview medical device human factors standards
Abbott overview medical device human factors standards
 
Quality Function Deployment (QFD) for Design Controls
Quality Function Deployment (QFD) for Design ControlsQuality Function Deployment (QFD) for Design Controls
Quality Function Deployment (QFD) for Design Controls
 
Pilot plant scale up techniques
Pilot plant scale up techniquesPilot plant scale up techniques
Pilot plant scale up techniques
 

Mehr von GirijaSoori

biostatistics.pptx research methodology
biostatistics.pptx  research methodologybiostatistics.pptx  research methodology
biostatistics.pptx research methodologyGirijaSoori
 
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptxMP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptxGirijaSoori
 
absorption of drugs.ppt
absorption of drugs.pptabsorption of drugs.ppt
absorption of drugs.pptGirijaSoori
 
keerthy sir lesson 1.pptx
keerthy sir lesson 1.pptxkeerthy sir lesson 1.pptx
keerthy sir lesson 1.pptxGirijaSoori
 
correlation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxcorrelation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxGirijaSoori
 
Factors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxFactors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxGirijaSoori
 

Mehr von GirijaSoori (6)

biostatistics.pptx research methodology
biostatistics.pptx  research methodologybiostatistics.pptx  research methodology
biostatistics.pptx research methodology
 
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptxMP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
 
absorption of drugs.ppt
absorption of drugs.pptabsorption of drugs.ppt
absorption of drugs.ppt
 
keerthy sir lesson 1.pptx
keerthy sir lesson 1.pptxkeerthy sir lesson 1.pptx
keerthy sir lesson 1.pptx
 
correlation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxcorrelation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptx
 
Factors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxFactors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptx
 

Kürzlich hochgeladen

THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 

Kürzlich hochgeladen (20)

THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 

Modern pharmaceutics

  • 1. URS-USER REQUIREMENT SPECIFICATIONS Presented by Girija G S M PHARM 1ST SEM DEPARTMENT OF PHARMACEUTICS MALLIGE COLLEGE OF PHARMACY 1
  • 2. 2 USER REQUIREMENT SPECIFICATIONS-URS → Requirements regarding equipment is given by users called as URS. It includes,  Size of equipment  Speed of equipment  Effectiveness of equipment  Availability of spares, change parts  Low dust and sound facilities  Auto control systems  Lesser breakdowns  Overall good construction
  • 3. 3  The requirement and specifications for the utility of equipment should be defined by the user and documented in the URS.  The URS should be used when selection of the required utility or equipment from an approved supplier and to verify suitability throughout the subsequent stages of qualification.  They must be comprehensive. Each and every requirement relating to product safety, identity, strength, purity, and quality must be identified.  The URS can contain a large number of requirements and should therefore be structured in a way that will permit easy access to information.  The requirement specification must be formally reviewed and approved by the pharmaceutical manufacturer.
  • 4. 4 The following guidelines should be followed during the production of the URS:  Each requirement statement to be uniquely referenced, and no longer than 250words.  Requirement statements should not be duplicated nor contradicted.  The URS should express requirements and not design solutions.  Each requirement should be testable.
  • 5. 5  The URS must be understood by both user and supplier; ambiguity avoided.  The use of diagrams is often useful  Wherever possible, the URS should distinguish between mandatory/regulatory requirements and desirable features.
  • 6. 6 U.R.S. for facilities is a statement spelling out, what the user wants in terms of the facilities, he wants to create for the manufacturing of the pharmaceutical formulations. It can expressed in the following manner. The facility will be used for the manufacture of the following formulation and volumes, namely: 1) Tablets-Coated 10L/Shift 2) Tablets-Uncoated 20L/Shift 3) Hard gelatin capsules 5L/Shift 4) Small volume parenterals 50K Amp/Shift 5) Large volume parenterals 20Kbottles of 500 ml/Shift
  • 7. 7 URS provides the following key benefits for the validation program: 1. Clarifies technical, quality, and documentation requirements to the vendor(s). 2. Enables the pharmaceutical manufacturer to assess the technical, regulatory, and commercial compliance (or otherwise) of submitted bids against a formal specification. 3. Ensures the basis of a structured approach to the presentation of information. 4. Provides a basis for testing and test acceptance criteria. 5. Provide a baseline for validation and verification..
  • 8. 8 Model Question 1) Write a note on USR?
  • 9. 9 References Pharmaceutical Process Validation, Second Edition, Revised and Expanded, edited by Ira R. Berry, Robert a. Nash. Validation in pharmaceutical industry; Equipment validation; A brief review, Diksha Jindal, et al; Adesh University Journal of Medical Sciences & Research. www.aujmsr.com
  • 10. 10